Regulatory role of FGF-2 on type I collagen expression during endothelial mesenchymal transformation

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 12, 2005, Pages 4495-4503

  Ko, MinHee K ^a   Kay, EunDuck P ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b DOHENY EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; FIBROBLAST GROWTH FACTOR 2; HEAT SHOCK PROTEIN 47; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN DISULFIDE ISOMERASE; RNA; 2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; ENZYME INHIBITOR; MESSENGER RNA; MORPHOLINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CORNEA ENDOTHELIUM; ENDOTHELIAL MESENCHYMAL TRANSFORMATION; ENDOTHELIUM CELL; GENE EXPRESSION; GOLGI COMPLEX; HALF LIFE TIME; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RABBIT; STEADY STATE; TRANSCRIPTION REGULATION; ANIMAL; BIOSYNTHESIS; CELL LINE; CELL PROLIFERATION; CONFOCAL MICROSCOPY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FLUORESCENCE MICROSCOPY; GENETICS; IMMUNOBLOTTING; MESODERM; METABOLISM; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CHROMONES; COLLAGEN TYPE I; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIUM, CORNEAL; ENZYME INHIBITORS; FIBROBLAST GROWTH FACTOR 2; IMMUNOBLOTTING; MESODERM; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MORPHOLINES; PHENOTYPE; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 33644792182     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0818     Document Type: Article

References (55)

1. Mishima S, Kaye GI, Takahashi GH, Kudo T, Trenberth SM. The function of the corneal endothelium in the regulation of hydration. In: Langham M, ed. The Cornea. Baltimore: Johns Hopkins University Press; 1969:207-237.
2. Waring GO III, Bourne WM, Edelhauser HF, Kenyon KR. The corneal endothelium: normal and pathologic structure and function. Ophthalmology. 1982;89:531-590.
3. Kaye G, Hoefle F, Sibley R. Recent studies on the nature and junction of the corneal endothelial barrier. Exp Eye Res. 1973;15:585-613.
4. Benya PD. EC collagen: biosynthesis by corneal endothelial cells and separation from type IV without pepsin treatment or denaturation. Ren Physiol. 1980;3:30-35.
5. Kay EP, Smith RE, Nimni ME. Basement membrane collagen synthesis by rabbit corneal endothelial cells in culture: evidence for an alpha chain derived from a larger biosynthetic precursor. J Biol Chem. 1982;257:7116-7121.
6. Waring GO III. Posterior collagenous layer of the cornea: ultrastructural classification of abnormal collagenous tissue posterior to Descemet's membrane in 30 cases. Arch Ophthalmol. 1982;100:122-134.
7. Kay EP. Expression of types I and IV collagen genes in normal and in modulated corneal endothelial cells. Invest Ophthalmol Vis Sci. 1989;30:260-268.
8. Leung EW, Rife L, Smith RE, Kay EP. Extracellular matrix components in retrocorneal fibrous membrane in comparison to corneal endothelium and Descemet's membrane. Mol Vis. 2000;6:15-23.
9. Yamaguchi N, Benya P, van der Rest M, Ninomiya Y. The cloning and sequencing of a1(VIII) collagen cDNAs demonstrate that type VIII collagen is a short chain collagen and contains triple-helical and carboxyl-terminal non triple-helical domains similar to those of type X collagen. J Biol Chem. 1989;264:16022-16029.
10. Kay EP, Gu X, Choi SH, Ninomiya Y. Posttranslational regulation of type I collagen in corneal endothelial cells. Invest Ophthalmol Vis Sci. 1996;37:11-19.
11. Ko MK, Kay EP. Subcellular localization of procollagen I and prolyl 4-hydroxylase in corneal endothelial cells. Exp Cell Res. 2001;264:363-371.
12. Ko MK, Kay EP. Differential interaction of molecular chaperones with procollagen I and type IV collagen in corneal endothelial cells. Mol Vis. 2002;8:1-9.
13. Wilson R, Lees JF, Bulleid NJ. Protein disulfide isomerase acts as a molecular chaperone during the assembly of procollagen. J Biol Chem. 1998;273:9637-9643.
14. Bottomley MJ, Batten MR, Lumb RA, Bulleid NJ. Quality control in the endoplasmic reticulum: PDI mediates the ER retention of unassembled procollagen C-propeptides. Curr Biol. 2001;11:1114-1118.
15. Hosokawa N, Nagata K. Procollagen binds to both prolyl 4-hydroxylase/protein disulfide isomerase and HSP47 within the endoplasmic reticulum in the absence of ascorbate. FEBS Lett. 2000;466:19-25.
16. Ko MK, Kay EP. PDI-mediated ER retention and proteasomal degradation of procollagen I in corneal endothelial cells. Exp Cell Res. 2004;295:25-35.
17. Fitzgerald J, Lamande SR, Bateman JF. Proteasomal degradation of unassembled mutant type I collagen pro-a1(I) chains. J Biol Chem. 1999;274:27392-27398.
18. Kay EP, Cheung CC, Jester JV, Nimni ME, Smith RE. Type 1 collagen and fibronectin synthesis by retrocorneal fibrous membrane. Invest Ophthalmol Vis Sci. 1982;22:200-212.
19. Brown SI, Kitano S. Pathogenesis of the retrocorneal membrane. Arch Ophthalmol. 1966;75:518-525.
20. Waring GO, Laibson PR, Rodrigues M. Clinical and pathologic alterations of Descemet's membrane: with emphasis on endothelial metaplasia. Surv Ophthalmol. 1974;18:325-368.
21. Kay EP, Smith RE, Nimni ME. Type I collagen synthesis by corneal endothelial cells modulated by polymorphonuclear leukocytes. J Biol Chem. 1985;260:5139-5146.
22. Michels RG, Kenyon KR, Maumence AE. Retrocorneal fibrous membrane. Invest Ophthalmol. 1972;11:822-831.
23. Kay EP, Gu X, Ninomiya Y, Smith RE. Corneal endothelial modulation: a factor released by leukocytes induces basic fibroblast growth factor that modulates cell shape and collagen. Invest Ophthalmol Vis Sci. 1993;34:663-672.
24. Kay EP, Gu X, Smith RE. Corneal endothelial modulation: bFGF as direct mediator and corneal endothelium modulation factor as inducer. Invest Ophthalmol Vis Sci. 1994;35:2427-2435.
25. Gu X, Seong GJ, Lee YG, Kay EP. Fibroblast growth factor 2 uses distinct signaling pathways for cell proliferation and cell shape changes in corneal endothelial cells. Invest Ophthalmol Vis Sci. 1996;37:2326-2334.
26. Kay EP, Park SY, Ko MK, Lee SC. Fibroblast growth factor 2 uses PLC-g1 for cell proliferation and PI3-kinase for alteration of cell shape and cell proliferation in corneal endothelial cells. Mol Vis. 1998;4:22-31.
27. Basilico C, Moscatelli D. The FGF family of growth factors and oncogenes. Adv Cancer Res. 1992;59:115-165.
28. Cornell RA, Kimelman D. Activin-mediated mesoderm induction requires FGF. Development. 1994;120:453-462.
29. Bikfalvi A, Savona C, Perollet C, Javerzat S. New insights in the biology of fibroblast growth factor-2. Angiogenesis. 1997;1:155-173.
30. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. Biological roles of fibroblast growth factor 2. Endocr Rev. 1997;18:26-45.
31. Sherman L, Stocker KM, Morrison R, Ciment G. Basic fibroblast growth factor (bFGF) acts intracellulary to cause the transdifferentiation of avian neural crest-derived Schwarm cell precursors into melanocytes. Development. 1993;118:1313-1326.
32. Slack JMW, Darlington BG, Heath JK, Godsave SF. Mesoderm induction in early Xenopus embryos by heparin-binding growth factors. Nature. 1987;326:197-200.
33. Power C, McLeskey SW, Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer. 2000;7:165-197.
34. Ullrich A, Schlessinger J. Signaling transduction by receptors with tyrosine kinase activity. Cell. 1990;61:203-212.
35. Klagsbrun M, Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell. 1991;67:229-231.
36. Lee HT, Kay EP. Regulatory role of PI 3-kinase on expression of Cdk4 and p27, nuclear localization of Cdk4, and phosphorylation of p27 in corneal endothelial cells. Invest Ophthalmol Vis Sci. 2003;44:1521-1528.
37. Kip1 by inhibiting phosphatidylinositol 3-kinase in corneal endothelial cells. Invest Ophthalmol Vis Sci. 2003;44:3816-3825.
38. Lee HT, Kay EP. FGF-2 induced reorganization and disruption of actin cytoskeleton through PI 3-kinase, Rho, and Cdc42 in corneal endothelial cells. Mol Vis. 2003;9:624-634.
39. Reif S, Lang A, Lindquist JN, et al. The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression. J Biol Chem. 2003;278:8083-8090.
40. Ricupero DA, Poliks CF, Rishikof DC, et al. Phosphatidylinositol 3-kinase-dependent stabilization of a1(I) collagen mRNA in human lung fibroblasts. Am J Physiol Cell Physiol. 2001;281:C99-C105.
41. Kay EP, Lee MS, Seong GJ, Lee YG. TGF-ās stimulate cell proliferation via an autocrine production of FGF-2 in corneal stromal fibroblasts. Curr Eye Res. 1998;17:286-293.
42. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
43. 14C in polyacrylamide gels by fluorography. Eur J Biochem. 1975;56:335-341.
44. Nakai A, Satoh M, Hirayoshi K, Nagata K. Involvement of the stress protein Hsp47 in procollagen processing in the endoplasmic reticulum. J Cell Biol. 1992;117:903-914.
45. Kay EP, He YG. Post-transcriptional and transcriptional control of collagen gene expression in normal and modulated rabbit corneal endothelial cells. Invest Ophthalmol Vis Sci. 1991;32:1821-1827.
46. Gu X, Ko MK, Kay EP. Intracellular interaction of Hsp47 and type I collagen in corneal endothelial cells. Invest Ophthalmol Vis Sci. 1999;40:289-295.
47. Tasab M, Batten MR, Bulleid NJ. Hsp47: a molecular chaperone that interacts with and stabilizes correctly-folded procollagen. EMBO J. 2000;19:2204-2211.
48. Ko MK, Kay EP. Hsp47-dependent and -independent intracellular trafficking of type I collagen in corneal endothelial cells. Mol Vis. 1999;5:17-24.
49. Freeman I. Collagen biosynthesis in the healing corneal wound. In: Schachan R, Levy N, Les Schachan L, eds. Keratorefraction. Denison, TX: LAL Publishing; 1980:39-50.
50. Narayanan AS, Page RC. Biochemical characterization of collagens synthesized by fibroblasts derived from normal and diseased human gingiva. J Biol Chem. 1976;251:5464-5471.
51. Moro L, Smith BD. Identification of collagen a1(I) trimer and normal type I collagen in a polyoma virus-induced mouse tumor. Arch Biochem Biophys. 1977;182:33-41.
52. Phillips CL, Pfeiffer BJ, Luger AM, Franklin CL. Novel collagen glomerulopathy in a homotrimeric type I collagen mouse (oim). Kidney Int. 2002;62:383-391.
53. 3 collagen mouse model. J Vasc Surg. 2001;33:1263-1270.
54. Stefanovic B, Hellerbrand C, Holcik M, et al. Posttranscriptional regulation of collagen a1(I) mRNA in hepatic stellate cells. Mol Cell Biol. 1997;17:5201-5209.
55. Lindquist JN, Parsons CJ, Stefanovic B, Brenner DA. Regulation of a1(I) collagen messenger RNA decay by interactions with aCP at the 3′-untranslated region. J Biol Chem. 2004;279:23822-23829.